0000899243-23-001111.txt : 20230105 0000899243-23-001111.hdr.sgml : 20230105 20230105204521 ACCESSION NUMBER: 0000899243-23-001111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Kevin Michael CENTRAL INDEX KEY: 0001951605 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 23513371 MAIL ADDRESS: STREET 1: 500 W. MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 203-360-4369 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0001932393 GE HealthCare Technologies Inc. GEHC 0001951605 O'Neill Kevin Michael 500 W. MONROE STREET CHICAGO IL 60661 0 1 0 0 CEO, PDx Common stock, par value $0.01 per share 2023-01-03 4 A 0 59 A 59 I By share incentive plan trust Employee Stock Option (right to buy) 129.52 2023-01-04 4 A 0 1653 A 2023-09-13 Common stock, par value $0.01 per share 1653 1653 D Employee Stock Option (right to buy) 142.15 2023-01-04 4 A 0 343 A 2024-09-05 Common stock, par value $0.01 per share 343 343 D Employee Stock Option (right to buy) 142.15 2023-01-04 4 A 0 3329 A 2024-09-05 Common stock, par value $0.01 per share 3329 3329 D Employee Stock Option (right to buy) 135.92 2023-01-04 4 A 0 3672 A 2025-09-11 Common stock, par value $0.01 per share 3672 3672 D Employee Stock Option (right to buy) 161.30 2023-01-04 4 A 0 5051 A 2026-09-30 Common stock, par value $0.01 per share 5051 5051 D Employee Stock Option (right to buy) 99.21 2023-01-04 4 A 0 5877 A 2027-11-17 Common stock, par value $0.01 per share 5877 5877 D Employee Stock Option (right to buy) 76.66 2023-01-04 4 A 0 4592 A 2028-03-19 Common stock, par value $0.01 per share 4592 4592 D Employee Stock Option (right to buy) 40.40 2023-01-04 4 A 0 13275 A 2028-12-21 Common stock, par value $0.01 per share 13275 13275 D Employee Stock Option (right to buy) 57.74 2023-01-04 4 A 0 3106 A 2029-03-19 Common stock, par value $0.01 per share 3106 3106 D Employee Stock Option (right to buy) 51.67 2023-01-04 4 A 0 1614 A 2029-04-11 Common stock, par value $0.01 per share 1614 1614 D Employee Stock Option (right to buy) 63.51 2023-01-04 4 A 0 10820 A 2030-03-02 Common stock, par value $0.01 per share 10820 10820 D Restricted Stock Units 2023-01-04 4 A 0 1622 A Common stock, par value $0.01 per share 1622 1622 D Restricted Stock Units 2023-01-04 4 A 0 6519 A Common stock, par value $0.01 per share 6519 6519 D Restricted Stock Units 2023-01-04 4 A 0 5568 A Common stock, par value $0.01 per share 5568 5568 D Restricted Stock Units 2023-01-04 4 A 0 9106 A Common stock, par value $0.01 per share 9106 9106 D The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is fully exercisable immediately and 50% will become exercisable on March 2, 2023. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 2023-01-05